Show simple item record

dc.contributor.authorMcCallum, Gabrielle
dc.contributor.authorGrimwood, Keith
dc.contributor.authorOguoma, Victor
dc.contributor.authorLeach, Amanda
dc.contributor.authorSmith-Vaughan, Heidi
dc.contributor.authorVersteegh, Lesley
dc.contributor.authorChang, Anne
dc.date.accessioned2020-03-31T02:56:22Z
dc.date.available2020-03-31T02:56:22Z
dc.date.issued2019
dc.identifier.issn0903-1936
dc.identifier.doi10.1183/13993003.congress-2019.PA306
dc.identifier.urihttp://hdl.handle.net/10072/392800
dc.description.abstractBackground: Candidate respiratory syncytial virus (RSV) vaccine trials in pregnant women and infants are underway and a greater understanding of RSV epidemiology is now needed, especially in paediatric populations with high rates of acute and chronic respiratory disease. Our study aimed to identify RSV prevalence in children living in northern Australia, a region with a high respiratory disease burden. Methods: Eleven prospective studies (four hospital- and seven community-based) of infants and children with acute and chronic respiratory illnesses, as well as otitis media, were conducted between 1996-2017 inclusive. The data for these trials were extracted and where available their nasopharyngeal swabs biobanked at -80°C were tested by polymerase chain reaction assays for RSV, 16 other viruses and atypical respiratory bacterial pathogens. Results: Of 1127 children included, the median age was 1.8-years (IQR 0.5-4.9); 58% were male, and 90% Indigenous. After human rhinoviruses (HRV), RSV was the second most prevalent virus (15%, 95%CI 13-18). RSV prevalence was greatest amongst children aged <2-years hospitalised with bronchiolitis (47%; 95%CI 41.4-52.4), where almost one-third were aged >6-months. In contrast, RSV prevalence was only 1-3.5% in other age groups and settings. In one-third of RSV cases, another respiratory virus was also detected. Individual viruses other than RSV and HRV were uncommon (0-9%). Conclusion: In northern Australia, effective maternal and infant RSV vaccines could substantially reduce RSV bronchiolitis-related hospitalisations, including admissions of Indigenous infants.
dc.languageEnglish
dc.publisherEuropean Respiratory Society
dc.relation.ispartofconferencenameEuropean-Respiratory-Society (ERS) International Congress
dc.relation.ispartofconferencetitleEUROPEAN RESPIRATORY JOURNAL
dc.relation.ispartofdatefrom2019-09-28
dc.relation.ispartofdateto2019-10-02
dc.relation.ispartoflocationMadrid, SPAIN
dc.relation.ispartofpagefrom2 pages
dc.relation.ispartofpageto2 pages
dc.relation.ispartofissuesuppl 63
dc.relation.ispartofvolume54
dc.subject.fieldofresearchMedical and Health Sciences
dc.subject.fieldofresearchcode11
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsRespiratory System
dc.subject.keywordsChildren
dc.subject.keywordsViruses
dc.titleThe point prevalence of respiratory syncytial virus in hospital and community-based studies in children from Northern Australia: studies in a 'high-risk' population
dc.typeConference output
dc.type.descriptionE3 - Conferences (Extract Paper)
dcterms.bibliographicCitationMcCallum, G; Grimwood, K; Oguoma, V; Leach, A; Smith-Vaughan, H; Versteegh, L; Chang, A, The point prevalence of respiratory syncytial virus in hospital and community-based studies in children from Northern Australia: studies in a 'high-risk' population, European Respiratory Journal, 2019, 54
dc.date.updated2020-03-31T02:54:54Z
gro.hasfulltextNo Full Text
gro.griffith.authorGrimwood, Keith
gro.griffith.authorSmith-Vaughan, Heidi


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Conference outputs
    Contains papers delivered by Griffith authors at national and international conferences.

Show simple item record